Chen Siting, Quiñones Ana R, Nagel Corey L, Bishop Nicholas J, Allore Heather G, Newsom Jason T, Kaye Jeffrey, Botoseneanu Anda
OHSU-PSU School of Public Health, Portland, Oregon, USA.
Department of Family Medicine, Oregon Health & Science University, Portland, Oregon, USA.
J Gerontol A Biol Sci Med Sci. 2025 Apr 7;80(5). doi: 10.1093/gerona/glaf009.
Racial/ethnic minoritized groups in the United States have a higher prevalence of cardiometabolic multimorbidity and experience a higher risk of dementia. This study evaluates the relationship between cardiometabolic multimorbidity and dementia onset according to racial/ethnic group in a nationally representative cohort of U.S. middle-aged and older adults.
Data from the Health & Retirement Study (1998-2018, N = 7,960, mean baseline age 59.4 years) and discrete-time survival models were used to estimate differences in the risk of dementia onset, defined by Langa-Weir classification. Models included race/ethnicity (non-Hispanic White, non-Hispanic Black, and Hispanic), chronic disease/multimorbidity categories (no disease, one disease, cardiovascular multimorbidity, metabolic multimorbidity, cardiometabolic multimorbidity, other multimorbidity), age, sex, education, wealth, body-mass index, and proxy status.
Over a mean follow-up of 14.6 years, 7.7% of the participants (n = 614) developed dementia. In the fully adjusted model, participants with cardiometabolic multimorbidity had the highest risk of dementia onset (HR:3.27, 95%CI: 2.06, 5.21), followed by metabolic (HR:1.83, 95%CI: 1.14, 2.94), and cardiovascular (HR:1.81, 95%CI: 1.24, 2.64) multimorbidity, relative to participants with no disease. The risk of dementia was significantly greater among Black (HR: 6.40, 95% CI: 3.84, 10.67) and Hispanic participants (HR: 4.90, 95% CI: 2.85, 8.43) with cardiometabolic multimorbidity, compared with White adults with no disease.
Individuals from racial/ethnic minoritized groups have a higher risk of dementia. The risk of dementia onset was significantly greater for Black and Hispanic participants experiencing cardiometabolic multimorbidity, highlighting the value of intervening in cardiometabolic conditions among middle-aged and older adults, in particular, those from racial/ethnic minoritized backgrounds to reduce the risk of developing dementia.
美国的少数族裔群体中心血管代谢共病的患病率较高,患痴呆症的风险也更高。本研究在美国具有全国代表性的中老年成年人队列中,根据种族/族裔群体评估心血管代谢共病与痴呆症发病之间的关系。
使用健康与退休研究(1998 - 2018年,N = 7960,平均基线年龄59.4岁)的数据和离散时间生存模型来估计根据兰加 - 韦尔分类定义的痴呆症发病风险差异。模型包括种族/族裔(非西班牙裔白人、非西班牙裔黑人、西班牙裔)、慢性病/共病类别(无疾病、一种疾病、心血管共病、代谢共病、心血管代谢共病、其他共病)、年龄、性别、教育程度、财富、体重指数和代理状态。
在平均14.6年的随访中,7.7%的参与者(n = 614)患上了痴呆症。在完全调整模型中,患有心血管代谢共病的参与者患痴呆症的风险最高(HR:3.27,95%CI:2.06,5.21),其次是代谢共病(HR:1.83,95%CI:1.14, 2.94)和心血管共病(HR:1.81,95%CI:1.24, 2.64),相对于无疾病的参与者。与无疾病的白人成年人相比,患有心血管代谢共病的黑人(HR:6.40,95%CI:3.84, 10.67)和西班牙裔参与者(HR:4.90,95%CI:2.85, 8.43)患痴呆症的风险显著更高。
少数族裔群体的个体患痴呆症的风险更高。患有心血管代谢共病的黑人和西班牙裔参与者患痴呆症的风险显著更高,这突出了干预中老年成年人,特别是少数族裔背景的成年人的心血管代谢状况以降低患痴呆症风险的价值。